UTHR · Insider Trading
United Therapeutics Corp
Every open-market purchase and sale reported by UTHR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-15 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$4.01M |
| 2026-10-14 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$4.06M |
| 2026-10-13 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$4.06M |
| 2026-10-13 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$4.11M |
| 2026-10-09 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.96M |
| 2026-10-08 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$4.10M |
| 2026-10-07 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$4.00M |
| 2026-10-06 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$4.03M |
| 2026-10-05 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$4.10M |
| 2026-10-02 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$4.36M |
| 2026-10-01 | Martine A Rothblatt | Chairperson & CEO | Sell | −1,920 | −$1.06M |
| 2026-10-01 | Paul A Mahon | EVP & GENERAL COUNSEL | MIXED | — | −$3.48M |
| 2026-10-01 | Martine A Rothblatt | Chairperson & CEO | MIXED | +1,920 | −$2.81M |
| 2026-09-30 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.42M |
| 2026-09-29 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.45M |
| 2026-09-28 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.40M |
| 2026-09-25 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.38M |
| 2026-09-24 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.55M |
| 2026-09-23 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.58M |
| 2026-09-22 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.58M |
| 2026-09-21 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.58M |
| 2026-09-18 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.59M |
| 2026-09-18 | Paul A Mahon | EVP & GENERAL COUNSEL | MIXED | — | −$2.92M |
| 2026-09-17 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.64M |
| 2026-09-16 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.65M |
| 2026-09-15 | Nilda Mesa | Director | MIXED | −98 | −$100.93K |
| 2026-09-15 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.67M |
| 2026-09-14 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.64M |
| 2026-09-11 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.65M |
| 2026-09-10 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.65M |
| 2026-09-09 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.62M |
| 2026-09-08 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.53M |
| 2026-09-04 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.36M |
| 2026-09-03 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.40M |
| 2026-09-03 | Paul A Mahon | EVP & GENERAL COUNSEL | MIXED | — | −$2.79M |
| 2026-09-02 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.60M |
| 2026-09-01 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.57M |
| 2026-08-31 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.63M |
| 2026-08-28 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.68M |
| 2026-08-27 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.63M |
| 2026-08-26 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.63M |
| 2026-08-25 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.58M |
| 2026-08-24 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.64M |
| 2026-08-21 | Paul A Mahon | EVP & GENERAL COUNSEL | MIXED | — | −$3.13M |
| 2026-08-21 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.66M |
| 2026-08-20 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.72M |
| 2026-08-19 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.61M |
| 2026-08-18 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.53M |
| 2026-08-17 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.45M |
| 2026-08-14 | Martine A Rothblatt | Chairperson & CEO | MIXED | — | −$3.50M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Paul A Mahon | EVP & GENERAL COUNSEL | 52,592 | $28.04M |
| Martine A Rothblatt | Chairperson & CEO | 49,415 | $26.34M |
| Michael Benkowitz | PRESIDENT AND COO | 28,625 | $15.26M |
| Richard Giltner | Director | 21,884 | $11.67M |
| James Edgemond | CFO AND TREASURER | 18,876 | $10.06M |
| Tommy G Thompson | Director | 16,680 | $8.89M |
| Ray Kurzweil | Director | 13,320 | $7.10M |
| Nilda Mesa | Director | 6,560 | $3.50M |
| Judy D. Olian | Director | 5,555 | $2.96M |
| Raymond Dwek | Director | 4,750 | $2.53M |
| Louis W Sullivan | Director | 4,440 | $2.37M |
| Christopher Causey | Director | 4,190 | $2.23M |
| Christopher Patusky | Director | 3,510 | $1.87M |
| Jan Malcolm | Director | 450 | $239.90K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the UTHR quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.